Zentalis Pharmaceuticals, Inc. · NASDAQ:ZNTL
WALTERS GROUP reported a 9.90% stake in Zentalis Pharmaceuticals, Inc. (Schedule 13G/A)
Event Jan 29, 2025 · Filed Jan 31, 2025
WALTERS GROUP reported a 9.90% stake in Zentalis Pharmaceuticals, Inc., 7,050,000 shares, as a passive investor on Jan 29, 2025. Filed Jan 31, 2025 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 7,050,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Walters William T | 9.90% | 7,050,000 |
| WALTERS GROUP | 9.90% | 7,050,000 |
| Walters, Susan B. | 9.90% | 7,050,000 |
Source
Related
- Zentalis Pharmaceuticals, Inc.
- Walters William Thurman
- Zentalis Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Walters William Thurman · Jan 22, 2025
- Schedule 13G/A · Walters William Thurman · Jan 8, 2025
- Form 4 · Bruns Ingmar · Oct 1, 2026
- Form 4 · Walters William Thurman · Aug 19, 2026
- Schedule 13G/A · Walters Group · Aug 19, 2026
- Schedule 13G/A · Barclays PLC · Aug 13, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026